These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34367981)

  • 1. Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience.
    Xie L; Xu J; Guo W; Wang Z; Yao Y; Li J; Lin J; Xiao J; Yu X; Zhang W; Cai Z; Hua Y; Chen J; Shao Z; Wu D; Wu S; Tu Z; Zhang X
    Front Oncol; 2021; 11():696865. PubMed ID: 34367981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.
    Xie L; Xu J; Sun X; Tang X; Yan T; Yang R; Guo W
    Oncologist; 2019 Jul; 24(7):e542-e550. PubMed ID: 30559126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of apatinib in advanced sarcoma: an open-label, nonrandomized, single-center study of 45 patients.
    Weitao Y; Fangxing W; Qiqing C; Jiaqiang W
    Anticancer Drugs; 2019 Aug; 30(7):e0778. PubMed ID: 31305297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China.
    Xie L; Guo W; Wang Y; Yan T; Ji T; Xu J
    BMC Cancer; 2018 Apr; 18(1):396. PubMed ID: 29625604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of apatinib in the treatment of osteosarcoma: a single-arm meta-analysis among Chinese patients.
    Yao H; Chen X; Tan X
    BMC Cancer; 2021 Apr; 21(1):449. PubMed ID: 33892656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma.
    Xie L; Xu J; Sun X; Tang X; Yan T; Yang R; Guo W
    Cancer Manag Res; 2020; 12():91-102. PubMed ID: 32021426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy and safety of apatinib combined with chemotherapy for osteosarcoma and soft tissue sarcoma with pulmonary metastasis].
    Li SL; Yang QK; Chen P; Zheng K; Wang W; Pei Y; Zhang XJ
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):309-314. PubMed ID: 31014058
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846.
    Liu X; Xu J; Li F; Liao Z; Ren Z; Zhu L; Shi Y; Zhao G; Bai X; Zhao J; Xing R; Teng S; Yang Y; Yang J
    Biomed Pharmacother; 2020 Feb; 122():109587. PubMed ID: 31786466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial.
    Xie L; Xu J; Sun X; Guo W; Gu J; Liu K; Zheng B; Ren T; Huang Y; Tang X; Yan T; Yang R; Sun K; Shen D; Li Y
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32376724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy.
    Liu Y; Hu X; Jiang J; Yang L; Zhou S; Liu P; Li J; Wang Y; Hao X; Shi Y
    Oncologist; 2020 May; 25(5):e833-e842. PubMed ID: 32250517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming therapeutic failure in osteosarcoma
    Li X; Wang L; Wang L; Yu J; Lu G; Zhao W; Miao C; Zou C; Wu J
    Biomater Sci; 2020 Oct; 8(21):5888-5899. PubMed ID: 33001086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China.
    Li F; Liao Z; Zhao J; Zhao G; Li X; Du X; Yang Y; Yang J
    Oncotarget; 2017 Sep; 8(38):64471-64480. PubMed ID: 28969086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself.
    Yang QK; Chen T; Wang SQ; Zhang XJ; Yao ZX
    Angiogenesis; 2020 Aug; 23(3):279-298. PubMed ID: 32333216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma.
    Rimassa L; Danesi R; Pressiani T; Merle P
    Cancer Treat Rev; 2019 Jul; 77():20-28. PubMed ID: 31195212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first-line treatment for advanced EGFR-mutant non-small cell lung cancer.
    Zhang Z; Zhang Y; Luo F; Ma Y; Fang W; Zhan J; Li S; Yang Y; Zhao Y; Hong S; Zhou T; Zhang Y; Zhao S; Huang Y; Zhao H; Zhang L
    Clin Transl Med; 2020 Jun; 10(2):e33. PubMed ID: 32508029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLC.
    Wu D; Liang L; Nie L; Nie J; Dai L; Hu W; Zhang J; Chen X; Han J; Ma X; Tian G; Han S; Long J; Wang Y; Zhang Z; Xin T; Fang J
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):446-452. PubMed ID: 29573236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma.
    Zhao J; Lei J; Yu J; Zhang C; Song X; Zhang N; Wang Y; Zhang S
    Invest New Drugs; 2020 Apr; 38(2):500-506. PubMed ID: 31650447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study.
    Liu X; Qin S; Wang Z; Xu J; Xiong J; Bai Y; Wang Z; Yang Y; Sun G; Wang L; Zheng L; Xu N; Cheng Y; Guo W; Yu H; Liu T; Lagiou P; Li J
    J Hematol Oncol; 2017 Sep; 10(1):153. PubMed ID: 28870253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of apatinib in patients with previously treated metastatic gastric cancer: a sub-analysis from the real-world study of apatinib for gastric cancer treatment (AHEAD-G202).
    Wang X; Yu J; Yang M; Liu L; Gao J; Ren Y; Zhang R; Zhong D; Du N; Fu Z; Jia J; Li Q; Diao J; Zhang J; Guo J; Li X; Song X; Zhang Y; Yu Z; Ma L; Fan Z; Liu Z; Li G; Liang F; Wang H; Gao Y; Yang P; Bai C; Zang A; Ren X
    Am J Cancer Res; 2020; 10(3):987-996. PubMed ID: 32266105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa.
    Assi A; Farhat M; Hachem MCR; Zalaquett Z; Aoun M; Daher M; Sebaaly A; Kourie HR
    J Bone Oncol; 2023 Dec; 43():100511. PubMed ID: 38058514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.